The Transition From Rome III to Rome IV Irritable Bowel Syndrome: What We Gain and Lose
Volume: 20, Issue: 3, Pages: 508 - 510
Published: Mar 1, 2022
Abstract
In a longitudinal survey study, Goodoory et al1Goodoory V.C. Houghton L.A. Yiannakou Y. et al.Natural history and disease impact of Rome IV vs Rome III irritable bowel syndrome: a longitudinal follow-up study.Clin Gastroenterol Hepatol. 2022; 20: 569-577Abstract Full Text Full Text PDF Scopus (6) Google Scholar compared the natural history of individuals with irritable bowel syndrome (IBS) defined by Rome IV criteria2Lacy B.E. Mearin F. Chang L....
Paper Details
Title
The Transition From Rome III to Rome IV Irritable Bowel Syndrome: What We Gain and Lose
Published Date
Mar 1, 2022
Volume
20
Issue
3
Pages
508 - 510
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History